Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes

Mechanisms of Ageing and Development

Volumn 124, Issue 4, 2003, Pages 495-502

  Pedersen, Maria ^a   Bruunsgaard, Helle ^a,b   Weis, Nina ^a   Hendel, Helle W ^a   Andreassen, Bente U ^a   Eldrup, Ebbe ^a   Dela, Flemming ^a   Pedersen, Bente K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Ageing; Cytokines; Fat mass; Sarcopenia

Indexed keywords

INTERLEUKIN 6; POTASSIUM; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; AGE; AGED; BODY FAT; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENDER; HUMAN; HYPOTHESIS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SENESCENCE; SKELETAL MUSCLE; TOTAL BODY POTASSIUM; TRUNK;

EID: 0037397789     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(03)00027-7     Document Type: Conference Paper

References (39)

1. Balagopal P., Rooyackers O.E., Adey D.B., Ades P.A., Nair K.S. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am. J. Physiol. 273:1997;E790-E800.
2. Bastard J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85:2000;3339-3342.
3. Bertin E., Nguyen P., Guenounou M., Durlach V., Potron G., Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab. 26:2000;178-182.
4. Bruunsgaard H., Andersen-Ranberg K., Jeune B., Pedersen A.N., Skinhoj P., Pedersen B.K. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J. Gerontol. A Biol. Sci. Med. Sci. 54:1999;M357-M364.
5. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8:2001;131-136.
6. Cheung A.T., Ree D., Kolls J.K., Fuselier J., Coy D.H., Bryer-Ash M. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology. 139:1998;4928-4935.
7. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83:1998;2907-2910.
8. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 51:2000;245-270.
9. Forbes B. Human Body Composition: Growth, Aging, Nutrition, and Activity. 1987;Springer, New York.
10. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83:1998;847-850.
11. Gallagher D., Ruts E., Visser M., Heshka S., Baumgartner R.N., Wang J., Pierson R.N., Pi-Sunyer F.X., Heymsfield S.B. Weight stability masks sarcopenia in elderly men and women. Am. J. Physiol. Endocrinol. Metab. 279:2000;E366-E375.
12. Gallagher D., Visser M., De Meersman R.E., Sepulveda D., Baumgartner R.N., Pierson R.N., Harris T., Heymsfield S.B. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J. Appl. Physiol. 83:1997;229-239.
13. Garaulet M., Perex-Llamas F., Fuente T., Zamora S., Tebar F.J. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur. J. Endocrinol. 143:2000;657-666.
14. Grunfeld C., Palladino M.A. Jr. Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv. Intern. Med. 35:1990;45-71.
15. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H. Jr., Heimovitz H., Cohen H.J., Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106:1999;506-512.
16. Hendel H.W., Gotfredsen A., Andersen T., Hojgaard L., Hilsted J. Body composition during weight loss in obese patients estimated by dual energy X-ray absorptiometry and by total body potassium. Int. J. Obes. Relat. Metab. Disord. 20:1996;1111-1119.
17. Hotamisligil G.S. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245:1999;621-625.
18. Howell S.J., Radford J.A., Adams J.E., Shalet S.M. The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition. Clin. Endocrinol. (Oxf). 52:2000;609-616.
19. Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab. Invest. 64:1991;724-742.
20. Katsuki A., Sumida Y., Murashima S., Murata K., Takarada Y., Ito K., Fujii M., Tsuchihashi K., Goto H., Nakatani K., Yano Y. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83:1998;859-862.
21. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280:2001;E745-E751.
22. Mishima Y., Kuyama A., Tada A., Takahashi K., Ishioka T., Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 52:2001;119-123.
23. Mohamed-Ali V., Goodrick S., Bulmer K., Holly J.M., Yudkin J.S., Coppack S.W. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am. J. Physiol. 277:1999;E971-E975.
24. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82:1997;4196-4200.
25. Moore, F., Olesen, K., McMurry, J., Parker, H., Ball, M., Boyden, C., 1963. The body cell mass and its supporting environment, bodycomposition in health and disease, Saunders, Philadelphia.
26. Pacifici R. Aging and cytokine production. Calcif. Tissue Int. 65:1999;345-351.
27. Pickup J.C., Chusney G.D., Thomas S.M., Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 67:2000;291-300.
28. Reid M.B., Li Y.P. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir. Res. 2:2001;269-272.
29. Ronnemaa T., Pulkki K., Kaprio J. Serum soluble tumor necrosis factor-alpha receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity. J. Clin. Endocrinol. Metab. 85:2000;2728-2732.
30. Stephens J.M., Butts M.D., Pekala P.H. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. J. Mol. Endocrinol. 9:1992;61-72.
31. Straub R.H., Hense H.W., Andus T., Scholmerich J., Riegger G.A., Schunkert H. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J. Clin. Endocrinol. Metab. 85:2000;1340-1344.
32. Taaffe D.R., Villa M.L., Holloway L., Marcus R. Bone mineral density in older non-Hispanic Caucasian and Mexican-American women: relationship to lean and fat mass. Ann. Hum. Biol. 27:2000;331-344.
33. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161:2001;397-405.
34. Volpato S., Guralnik J.M., Ferrucci L., Balfour J., Chaves P., Fried L.P., Harris T.B. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation. 20:(103):2001;947-953.
35. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., Jansson J. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8:2002;75-79.
36. Wang Q., Hassager C., Ravn P., Wang S., Christiansen C. Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related? Am. J. Clin. Nutr. 60:1994;843-848.
37. Womersley J., Boddy K., King P.C., Durnin J.V. A comparison of the fat-free mass of young adults estimated by anthropometry, body density and total body potassium content. Clin. Sci. 43:1972;469-475.
38. Woods A., Brull D.J., Humphries S.E., Montgomery H.E. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur. Heart J. 21:2000;1574-1583.
39. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., Achong M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:1998;311-320.